Painreform Company Insiders

PRFX Stock  USD 2.28  -0.01  -0.44%   
Painreform employs about 2 people. The company is managed by 11 executives with a total tenure of roughly 5 years, averaging almost 0.0 years of service per executive, having 0.18 employees per reported executive. For Painreform, management analysis can help investors test whether leadership decisions are reinforcing the broader investment thesis or creating new operating risk. Used properly, management analysis helps separate durable execution from results that may only reflect a supportive market cycle.

Painreform's Workforce Through the Years

A workforce review of Painreform matters because hiring and staffing trends often say something about growth plans, cost discipline, and management expectations. The working assumption is a workforce near about 10 employees by April 2026, though investors should still compare that path with broader business results.
Macro event markers
 
Covid
 
Interest Hikes

Management Team Effectiveness

The company has return on total asset (ROA) of -36.19 % which means that for every $100 of assets, it generated a loss of $36.19. This is well below the sector average. Similarly, it shows a return on stockholder's equity (ROE) of -127.65 %, which implies that it generated no returns to current stockholders.

Insider Trading Activities

Insider activity around Painreform matters because officers and directors often act on business changes before the market catches up. Current market capitalization is about 1.87 Million. These records work best as context, not as standalone buy-or-sell signals.
 
Shavit Asaf few days ago
Insider Trading

Outstanding Bonds

Painreform may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. Longer-dated obligations can improve financing stability, but they also leave investors more exposed if the underlying business weakens before the debt matures.
Painreform maintains a 9.39% of its outstanding shares held by insiders and 2.45% owned by institutional investors. Institutions collectively hold about 2% of Painreform's shares, insiders own approximately 9%, and the remaining 88% is in public hands.

Holders Distribution

A large institutional presence around Painreform deserves attention because well-resourced investors can establish or unwind positions quickly enough to change the market character of the security. The opportunity for retail investors is not to imitate blindly, but to understand how large-holder positioning may affect liquidity, volatility, and timing.

Workforce Comparison

Painreform is rated below average in number of employees among leading competitors. The total workforce of Health Care industry is at this time estimated at about 350. Painreform maintains roughly 2.0 in number of employees contributing less than 1% to equities under Health Care sector.

Insider Trading History

The insider timeline for Painreform shows how management behavior has tracked against the stock's price over time. Shares outstanding are near 2 M. Since insider trades are publicly filed, the record helps verify whether management actions match their words.

Notable Stakeholders

Stakeholder analysis for Painreform is useful because companies often face trade-offs among groups that want very different outcomes from the same business. Used properly, stakeholder review supports staying aware of the people and incentives that may be shaping key decisions behind the scenes.
Ilan MBACEO CFOProfile
Ehud GellerExecutive ChairmanProfile
Efraim CohenAraziInterim DirectorProfile
Sigal AvielChief OfficerProfile
Rita MScVice OperationsProfile
Rita KeynanVice OperationsProfile
Eyal BroderInterim OfficerProfile
MBA MBACEO CFOProfile
Pr HazumCTO DirectorProfile
Stephen DMDExecutive DevelopmentProfile
Sigal eMBAChief OfficerProfile

Management Information & Data Sources

Painreform is a micro-cap company in NASDAQ Composite. Executive review focuses on insiders, senior management, and employee signals. Employee count and organizational scale can help frame operating leverage and execution complexity. CEO is Ilan MBA with 2 employees and 11 reported executives.

This section for Painreform is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Insider and management fields are mapped from published filings and company disclosures.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 19th, 2026

Workforce Efficiency and Productivity

Investors reviewing Painreform can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. Used correctly, manpower metrics can highlight whether growth is being supported by better productivity or by heavier staffing costs.

Painreform Manpower Efficiency

Return on Painreform Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee7.3M
Net Loss Per Executive1.3M
Working Capital Per Employee993K
Working Capital Per Executive180.5K

Popular Tools for Painreform Stock analysis

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments